Klinik Bremen-Mitte; Prof. Hess-Kinderklinik

Bremen 28177

0 studies enrolling now · 2 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) — Completed
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed